Observational studyEuropean journal of haematology2026

Real-World Effectiveness and Safety of Damoctocog Alfa Pegol in Severe and Nonsevere Patients With Hemophilia A From the Prospective, Multinational, Ongoing HEM-POWR Study.

Mark T Reding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.